$69.01
0.00% today
Nasdaq, Sep 15, 03:45 pm CET
ISIN
US8064071025
Symbol
HSIC

Henry Schein Stock price

$69.01
+1.51 2.24% 1M
-0.93 1.33% 6M
-0.19 0.27% YTD
+0.84 1.23% 1Y
-5.84 7.80% 3Y
+5.28 8.29% 5Y
+15.90 29.95% 10Y
+51.98 305.12% 20Y
Nasdaq, Closing price Fri, Sep 12 2025
-0.54 0.78%

Key metrics

Basic
Market capitalization
$8.4b
Enterprise Value
$11.2b
Net debt
$2.9b
Cash
$145.0m
Shares outstanding
121.9m
Valuation (TTM | estimate)
P/E
21.8 | 14.0
P/S
0.7 | 0.6
EV/Sales
0.9 | 0.8
EV/FCF
33.7
P/B
2.4
Financial Health
Equity Ratio
33.2%
Return on Equity
11.5%
ROCE
9.8%
ROIC
6.1%
Debt/Equity
0.9
Financials (TTM | estimate)
Revenue
$12.8b | $13.3b
EBITDA
$1.0b | $1.1b
EBIT
$777.0m | $978.7m
Net Income
$389.0m | $599.9m
Free Cash Flow
$334.0m
Growth (TTM | estimate)
Revenue
2.3% | 4.6%
EBITDA
20.0% | 10.7%
EBIT
25.9% | 32.8%
Net Income
10.5% | 53.8%
Free Cash Flow
-29.7%
Margin (TTM | estimate)
Gross
31.3%
EBITDA
8.1% | 8.5%
EBIT
6.1%
Net
3.1% | 4.5%
Free Cash Flow
2.6%
More
EPS
$3.2
FCF per Share
$2.7
Short interest
8.2%
Employees
25k
Rev per Employee
$510.0k
Show more

Is Henry Schein a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,015 stocks worldwide.

Henry Schein Stock Analysis

Unlock Scores for Free

Analyst Opinions

23 Analysts have issued a Henry Schein forecast:

10x Buy
43%
12x Hold
52%
1x Sell
4%

Analyst Opinions

23 Analysts have issued a Henry Schein forecast:

Buy
43%
Hold
52%
Sell
4%

Financial data from Henry Schein

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
12,773 12,773
2% 2%
100%
- Direct Costs 8,771 8,771
3% 3%
69%
4,002 4,002
1% 1%
31%
- Selling and Administrative Expenses 2,972 2,972
4% 4%
23%
- Research and Development Expense - -
-
-
1,030 1,030
20% 20%
8%
- Depreciation and Amortization 253 253
5% 5%
2%
EBIT (Operating Income) EBIT 777 777
26% 26%
6%
Net Profit 389 389
11% 11%
3%

In millions USD.

Don't miss a Thing! We will send you all news about Henry Schein directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Henry Schein Stock News

Neutral
Seeking Alpha
5 days ago
Henry Schein, Inc. (NASDAQ:HSIC ) Baird Global Healthcare Conference 2025 September 10, 2025 10:50 AM EDT Company Participants Stanley Bergman - Executive Chairman & CEO Andrea Albertini - Chief Executive Officer of Global Distribution & Technology Tom Popeck - Chief Executive Officer of Henry Schein Products Group Ronald South - Senior VP & CFO Conference Call Participants Jeffrey Johnson - Ro...
Neutral
Business Wire
6 days ago
MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein, Inc. (Nasdaq: HSIC), the world's largest provider of health care products and services to office-based dental and medical practitioners, announced today that its Board of Directors has authorized the repurchase of up to $750 million of shares of the Company's common stock. This program is in addition to the $500 million repurchase program announced...
Neutral
PRNewsWire
6 days ago
Full-Service Laboratory Management Firm Helps Elevate Clinical Lab Operations NEW YORK , Sept. 9, 2025 /PRNewswire/ -- Henry Schein Medical, the U.S. medical business of Henry Schein, Inc., has expanded its SolutionsHub™ with the addition of Colaborate, a full-service management consulting firm dedicated to serving independent and hospital-based medical laboratories.
More Henry Schein News

Company Profile

Henry Schein, Inc. engages in the provision of health care products and services to medical, dental, and veterinary office-based practitioners. It operates through the Healthcare Distribution, and Technology and Value-Added Services segments. The Healthcare Distribution segment includes consumable products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products and vitamins. The Technology & Value-Added Services segment offers financial services on a non-recourse basis, e-services practice, technology, network and hardware services. The company was founded by Henry Schein and Esther Schein in 1932 and is headquartered in Melville, NY.

Head office United States
CEO Stanley Bergman
Employees 25,000
Founded 1932
Website www.henryschein.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today